EC Clinical and Medical Case Reports

Placental mesenchymal dysplasia (PMD) resembles molar pregnancy quite a bit. Because there have been documented live births of healthy babies, obtaining an objective diagnosis is crucial to assisting the mother in making an educated decision on what option of management she would like to explore. Prenatal invasive testing is recommended to help obtain an objective diagnosis in all cases of abnormal placenta. We present a 23 years old who, at 14 weeks, had ultrasonographic findings suggestive of placental mesenchymal dysplasia. She was offered prenatal invasive testing but declined and opted for surgical management, with a diagnosis of PMD confirmed on histopathology. There will be occasions such as this when prenatal invasive testing is declined. This case report helps describe how careful consideration can be given to color doppler and MRI in such situations, especially if the patient decides to keep the pregnancy.

 Keywords: Color Doppler; Molar Pregnancy; MRI; Placental Mesenchymal Dysplasia

1. Guenot C., et al. “Placental mesenchymal dysplasia: An underdiagnosed placental pathology with various clinical outcomes”. European Journal of Obstetrics and Gynecology and Reproductive Biology 234 (2019): 155-164.
2. Shigeki Taga., et al. "A case of placental mesenchymal dysplasia". Case Reports in Obstetrics and Gynecology (2013): 265159.
3. Woo GW., et al. “Placenta mesenchymal dysplasia”. American Journal of Obstetrics and Gynecology 6 (2011): e3-e5.
4. Tidy J., et al. “Management of gestational trophoblastic disease”. BJOG: An International Journal of Obstetrics and Gynaecology3 (2021): e1-e27.
5. Arizawa M and Nakayama M. “Suspected involvement of the X chromosome in placental mesenchymal dysplasia”. Congenital Anomalies 4 (2002): 309-317.
6. Moscoso G., et al. “Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity?” Pathology - Research and Practice 2-3 (1991): 324-328.
7. Tang P., et al. “Misdiagnosis of placental mesenchymal dysplasia as pregnancy with hydatidiform mole: A case report and literature review”. Medicine15 (2023): e33438.
8. Schiffer V., et al. “Ultrasound evaluation of the placenta in healthy and placental syndrome pregnancies: A systematic review”. European Journal of Obstetrics and Gynecology and Reproductive Biology 262 (2021): 45-56.
9. Gavanier D., et al. “Ultrasound findings and clinical outcomes in 23 cases of placental mesenchymal dysplasia”. Journal of Reproductive Medicine4 (2017): 366-375.
10. Mehedintu C., et al. “A challenging diagnosis: placental mesenchymal dysplasia-literature review and case report”. Diagnostics2 (2022): 293.
11. Placental mesenchymal dysplasia. Free Online Library (2024).
12. Kuwata T., et al. “‘Stained‐glass’ sign for placental mesenchymal dysplasia”. Ultrasound in Obstetrics and Gynecology3 (2014): 355.
13. Jauniaux E., et al. “Perinatal features associated with placental mesenchymal dysplasia”. Placenta8 (1997): 701-706.
14. Himoto Y., et al. “Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging”. Journal of Obstetrics and Gynaecology Research7 (2014): 1894-1900.
15. Torloni MR., et al. “Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis”. Ultrasound in Obstetrics and Gynecology5 (2009): 599-608.
16. Kanal E., et al. “ACR guidance document on MR safe practices: 2013”. Journal of Magnetic Resonance Imaging3 (2013): 501-530.